Question

An emerging cost containment strategy is to encourage comparative clinical effectiveness research (CER). The American Reinvestment and Recovery Act of 2009 introduced a broad economic stimulus package that included provisions to expand CER. Congress allocated $1.1 billion to this endeavor, providing funding to AHRQ, NIH, and HHS. CER remains controversial among physicians and elected officials, however. What is your position on this issue?

Answer 1

I think this type of controversies are common when big amounts are allowed for research purpose .so find out reason for this controversies and rsearch can be continued as it is related to health.this woulc be beneficial for the people of the country.